サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1791494

自動およびクローズド細胞治療処理システムの世界市場

Automated and Closed Cell Therapy Processing Systems

出版日
ページ情報
英文 138 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
自動およびクローズド細胞治療処理システムの世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 138 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動およびクローズド細胞治療処理システムの世界市場は2030年までに48億米ドルに達する

2024年に15億米ドルと推定される自動およびクローズド細胞治療処理システムの世界市場は、2024年から2030年にかけてCAGR 21.2%で成長し、2030年には48億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分離ワークフローは、CAGR 24.2％を記録し、分析期間終了までに14億米ドルに達すると予想されます。拡張ワークフロー分野の成長率は、分析期間でCAGR 22.5％と推定されます。

米国市場は4億20万米ドルと推定、中国はCAGR19.9％で成長予測

米国の自動およびクローズド細胞治療処理システム市場は、2024年に4億20万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを19.9%として、2030年までに7億3,240万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ19.9%と18.1%と予測されています。欧州では、ドイツがCAGR約15.2%で成長すると予測されています。

世界の自動およびクローズド細胞治療処理システム市場- 主要動向と促進要因まとめ

なぜ自動化システムとクローズドシステムが細胞治療処理に変革をもたらすのか？

自動およびクローズド細胞治療処理システムは、効率を改善し、汚染リスクを低減し、一貫した製品品質を確保することで、細胞治療製造に革命をもたらしています。これらのシステムは、細胞の分離、拡大、保存のための自動化されたワークフローを統合し、CAR-T細胞や幹細胞を用いた治療などの製造を合理化します。手作業による介入を最小限に抑えることで、スケーラビリティと規制遵守を強化し、細胞治療生産における重要な課題に対処します。細胞ベースの治療に対する需要が高まるにつれ、自動化システムは業界のニーズを満たすために不可欠なものとなりつつあります。

どのような動向が細胞治療プロセスにおけるイノベーションを牽引しているのか？

いくつかの動向が自動およびクローズド細胞治療処理システムの市場を形成しています。個別化医療の台頭は、患者に特化した治療法を製造できるシステムの需要を促進しています。自動化とロボット工学の技術的進歩により、精密で再現性の高いワークフローが可能になりつつあります。データ分析とIoT機能の統合により、プロセスのモニタリングと品質管理が強化されています。加えて、ポイント・オブ・ケア生産による製造の分散化がますます重視されるようになり、コンパクトでポータブルなシステムの採用が進んでいます。

これらのシステムは細胞治療のエコシステムをどのように強化しているか？

自動およびクローズドシステムは、製造におけるボトルネックに対処し、製品の安全性と有効性を確保することで、細胞治療のエコシステムを強化しています。これらのシステムは迅速な製造のスケールアップを可能にし、より多くの患者集団に対する治療法の商業化を促進します。リアルタイムモニタリングとトレーサビリティ機能は、厳しい規制基準へのコンプライアンスを向上させる。さらに、施設間でプロセスを標準化できるため、一貫した品質が確保され、治療結果のばらつきが減少します。こうした貢献により、多様な治療領域で細胞ベースの治療法の導入が加速しています。

自動およびクローズド細胞治療処理システム市場の成長を促すものは何か？

自動およびクローズド細胞治療処理システム市場の成長の原動力は、細胞ベースの治療に対する需要の増加、自動化技術の進歩、一貫した製造方法に対する規制要件です。がんや遺伝性疾患の有病率の上昇により、スケーラブルな生産ソリューションに対する需要が高まっています。バイオ医薬品企業と技術プロバイダーとのコラボレーションは、技術革新を加速し、市場アクセスを拡大しています。さらに、細胞治療研究を支援する政府の資金援助やイニシアチブは、自動化システムの採用を促進し、市場の持続的成長を確実なものにしています。

セグメント

ワークフロー（分離、拡大、アフェレーシス、充填と終了、凍結保存、その他のワークフロー）、タイプ（非幹細胞療法、幹細胞療法）

調査対象企業の例

  • BioSpherix（R）, LLC
  • Cellares Corporation
  • Cytiva
  • Danaher Corporation
  • Fresenius Kabi AG
  • Lonza, Inc.
  • Miltenyi Biotec
  • Sartorius AG
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ThermoGenesis Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29320

Global Automated and Closed Cell Therapy Processing Systems Market to Reach US$4.8 Billion by 2030

The global market for Automated and Closed Cell Therapy Processing Systems estimated at US$1.5 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 21.2% over the analysis period 2024-2030. Separation Workflow, one of the segments analyzed in the report, is expected to record a 24.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Expansion Workflow segment is estimated at 22.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$400.2 Million While China is Forecast to Grow at 19.9% CAGR

The Automated and Closed Cell Therapy Processing Systems market in the U.S. is estimated at US$400.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$732.4 Million by the year 2030 trailing a CAGR of 19.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.9% and 18.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Global Automated and Closed Cell Therapy Processing Systems Market - Key Trends & Drivers Summarized

Why Are Automated and Closed Systems Transforming Cell Therapy Processing?

Automated and closed cell therapy processing systems are revolutionizing cell therapy manufacturing by improving efficiency, reducing contamination risks, and ensuring consistent product quality. These systems integrate automated workflows for cell isolation, expansion, and preservation, streamlining the production of therapies such as CAR-T cells and stem cell-based treatments. By minimizing manual intervention, they enhance scalability and regulatory compliance, addressing critical challenges in cell therapy production. As the demand for cell-based therapies grows, automated systems are becoming indispensable for meeting industry needs.

What Trends Are Driving Innovation in Cell Therapy Processing?

Several trends are shaping the market for automated and closed cell therapy processing systems. The rise of personalized medicine has fueled demand for systems capable of producing patient-specific therapies. Technological advancements in automation and robotics are enabling precise and reproducible workflows. The integration of data analytics and IoT features is enhancing process monitoring and quality control. Additionally, the increasing focus on decentralizing manufacturing through point-of-care production is driving the adoption of compact and portable systems.

How Are These Systems Enhancing the Cell Therapy Ecosystem?

Automated and closed systems are enhancing the cell therapy ecosystem by addressing bottlenecks in manufacturing and ensuring product safety and efficacy. These systems enable rapid scale-up of production, facilitating the commercialization of therapies for larger patient populations. Real-time monitoring and traceability features improve compliance with stringent regulatory standards. Moreover, the ability to standardize processes across facilities ensures consistent quality, reducing variability in therapy outcomes. These contributions are accelerating the adoption of cell-based treatments across diverse therapeutic areas.

What Drives the Growth in the Automated and Closed Cell Therapy Processing Systems Market?

The growth in the automated and closed cell therapy processing systems market is driven by increasing demand for cell-based therapies, advancements in automation technologies, and regulatory requirements for consistent manufacturing practices. The rising prevalence of cancer and genetic disorders has created a robust demand for scalable production solutions. Collaborations between biopharma companies and technology providers are accelerating innovation and expanding market access. Additionally, government funding and initiatives supporting cell therapy research are fostering the adoption of automated systems, ensuring sustained market growth.

SCOPE OF STUDY:

The report analyzes the Automated and Closed Cell Therapy Processing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Workflow (Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow, Other Workflows); Type (Non-Stem Cell Therapy, Stem Cell Therapy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • BioSpherix(R), LLC
  • Cellares Corporation
  • Cytiva
  • Danaher Corporation
  • Fresenius Kabi AG
  • Lonza, Inc.
  • Miltenyi Biotec
  • Sartorius AG
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ThermoGenesis Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Automated and Closed Cell Therapy Processing Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Cell and Gene Therapy Pipelines Drive Demand for Automated Processing
    • Need for Sterility and Standardization Boosts Adoption of Closed Systems
    • Reduction of Manual Errors Encourages Use of Automated Platforms
    • Expansion of GMP-Compliant Facilities Accelerates System Integration
    • Shortage of Skilled Technicians Supports Market for User-Friendly Automation
    • Advances in Integrated Bioprocessing Systems Improve Efficiency
    • Increased Investment by Biopharma Companies in In-House Manufacturing
    • Rising Adoption of Personalized Cell Therapies Requires Scalable Platforms
    • End-to-End Automation Enables Faster Turnaround and Cost Savings
    • Cloud-Based Data Logging Enhances Process Monitoring and Compliance
    • Miniaturization of Cell Processing Units Improves Flexibility and Portability
    • Expansion of CAR-T and T-Cell Therapies Accelerates Equipment Demand
    • Collaboration Between Biotech and Equipment Manufacturers Drives Innovation
    • Growing Focus on Patient-Specific Manufacturing Spurs Customizable Solutions
    • Regenerative Medicine Growth Expands Applications Beyond Oncology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated and Closed Cell Therapy Processing Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Separation Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Separation Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Expansion Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Expansion Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Apheresis Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Apheresis Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fill- Finish Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Fill- Finish Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cryopreservation Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cryopreservation Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Workflows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Workflows by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Non-Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Non-Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • JAPAN
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • CHINA
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • EUROPE
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • FRANCE
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • GERMANY
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Germany 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Italy 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • UNITED KINGDOM
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030

IV. COMPETITION